Last edition
News about "AnGes and Boehringer Ingelheim Advance PAD Gene Th"
AnGes and Boehringer Ingelheim Advance PAD Gene Therapy with New Manufacturing Deal
Boehringer Ingelheim has signed a contract development and manufacturing agreement with AnGes Inc. for the drug substance of AnGes’ investigational therapy for peripheral arterial disease (PAD). This agreement marks a key step following AnGes’ recent completion of clinical trials and its plan to submit a biologics license application (BLA).
AnGes And Boehringer Ingelheim Advance PAD Gene Th | 21/08/2025 | By Darshana | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy